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ABSTRAK
Seorang wanita usia 59 tahun dengan hipotiroidisme dermatitis kontak akut berkembang menjadi selulitis 
dengan infeksi bakteri superimposed dan cedera ginjal akut. Dia merespons penatalaksanaan awal dengan 
antibiotik, namun seminggu kemudian mengalami vaskulitis kulit dan sistemik. Biopsi kulit konsisten dengan 
vaskulitis leuko-sitoklastik yang dimediasi imun dan hasil tes darah positif antibodi sitoplasma-anti-neutrofil 
sitoplasma (c-ANCA). Diagnosis vaskulitis terkait ANCA ditegakkan. Wanita tersebut dirawat dengan 
imunosupresan plasmaferesis dan dukungan hemodialisis untuk gagal ginjalnya. Laporan kasus ini menunjukkan 
bahwa infeksi jaringan lunak dapat memicu perkembangan vaskulitis terkait ANCA, latar belakang hipotiroidisme 
berfungsi sebagai faktor predisposisi karena kedua kondisi tersebut dilaporkan secara terpisah dalam beberapa 
studi kasus sebelumnya.
Kata kunci: selulitis, anti-neutrophil cytoplasmic antibodi, vaskulitis.
ABSTRACT
A 59-year-old lady with underlying hypothyroidism presented with acute contact dermatitis progressed to 
cellulitis with superimposed bacterial infection and acute kidney injury. She responded to initial management 
with antibiotics, but a week later, she had cutaneous and systemic vasculitis. Her skin biopsy consistent with 
immune-mediated leuko-cytoclastic vasculitis and her blood test was positive for cytoplasmic-anti-neutrophil 
cytoplasmic antibody (c-ANCA). A diagnosis of ANCA-associated vasculitis was made and she was treated with 
immunosuppressant with plasmapheresis and hemodialysis support for her kidney failure. Despite aggressive 
measures, the patient succumbed to her illness. This case report demonstrates that soft tissue infection could 
trigger the development of ANCA-associated vasculitis whilst a background of hypothyroidism serves as a 
predisposing factor as both condition were reported separately in a couple of case studies before.
Keywords: cellulitis, anti-neutrophil cytoplasmic antibody, vasculitis.
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INTRODUCTION
ANCA associated vasculitis (AAV) is a small 
vessel vasculitis (SVV) which is necrotizing 
in nature with few or no immune deposits. It 
is associated with myeloperoxidase (MPO)-
ANCA or proteinase 3 (PR3)-ANCA antibody. In 
literature, AAV is divided into 3 main categories 
namely microscopic polyangiitis (MPA), 
granulomatosis with polyangiitis (GPA), and 
eosinophilic granulomatosis with polyangiitis 
(EGPA).1 Despite a better understanding of 
the disease, the classification of AAV remains 
tricky because of the unknown etiology and 
considerable overlap in the clinical expression 
of these vasculitis syndromes.
It is well known that all the three types 
of AAV have common clinical presentations, 
including some of the non-specific inflammatory 
symptoms and signs such as malaise, fever, 
anemia, weight loss, rashes and synovitis. 
Therefore the exact diagnosis is often elusive 
and complex.2 As for now, to establish the 
definitive diagnosis of AAV warrant a collective 
assessment of clinical manifestations, a biopsy of 
the involved organ and the positivity of ANCA 
in the plasma. In view of malignant nature of 
untreated AAV, high clinical suspicion, early 
recognition and management are vital to retard 
the progression and to prevent life-threatening 
complications of the disease.
Here, we describe a case of multi-systemic 
AAV precipitated by soft tissue infection in a 
patient with underlying thyroid disease that 
potentially increases the likelihood of such 
association.
CASE ILLUSTRATION
A 59-year-old lady with underlying 
hypothyroidism on thyroxine replacement 
for 2 years, presented with bilateral feet 
pain for one month duration. She consulted 
primary healthcare and was treated with oral 
analgesic (Meloxicam - Mobic®) and vitamin 
supplements. A week later, as her feet got worse 
and became erythematous, she soaked her feet 
in cleansing solution (Dettol®) for disinfection 
purposes. Unfortunately, her feet started to 
develop multiple blisters which caused her to 
come to our hospital. She denied any history of 
fever and did not receive any antibiotic prior to 
her admission.
Physical examination revealed few oral 
ulcers as well as blisters and erythema of both 
feet. She was afebrile and her vital signs were 
normal with blood pressure (BP) of 129/69 
mmHg and pulse rate (PR) of 117 beats 
per minute (bpm). Investigations showed a 
total white count of 19.9x109/L and raised 
C-reactive protein (CRP) of 21.89 mg/dL. She 
had normochromic normocytic anemia with 
hemoglobin (Hb) of 8.7 g/dL whilst her renal 
profile was deranged with urea of 13.0 mmol/L 
and creatinine of 222µmol/L. Her baseline 
creatinine 6 months earlier was normal at 
63.5µmol/L. Other systemic examination and 
investigations were unremarkable. Her lungs 
were clear with normal chest X-ray.
She was diagnosed to have acute contact 
dermatitis of both feet and cellulitis with 
superimposed bacterial infection with non-
steroidal anti-inflammatory drugs (NSAIDs) 
(cyclo-oxygenase-2 inhibitor) induced acute 
kidney injury (AKI). She was started on 
intravenous (IV) ampicillin-sulbactam, potassium 
permanganate soak of her feet twice a day and 
oral Prednisolone of 20 mg daily with tapering 
every 3 days. Her serum creatinine peaked 
at 242.9 µmol/L. She completed a week of 
antibiotic, her feet and kidney function improved 
whilst her serum creatinine upon discharge was 
198µmol/L. She was planned for clinic review 
and given Betamethasone cream with her usual 
thyroxine replacement of 75 µg daily.
Unfortunately, a week later, she was 
readmitted with fever and pus discharge from 
the wounds of her feet. Physical examination 
showed swollen macerated feet with cracked 
skin and pus discharge. There were purpuric 
rashes found bilaterally up till her thighs. She 
was febrile with BP of 120/75 mmHg and PR 
of 110 bpm. Blood investigations revealed 
worsening anemia with Hb of 6.6 g/dL, white 
cell count (WCC) of 11x109/L, CRP of 25 mg/
dL, severe hyponatraemia with serum sodium of 
118 mmol/L, worsening AKI with urea of 25.7 
mmol/L and creatinine of 959 µmol/L. She has 
no evidence of gastro-intestinal bleed and did 
not take any NSAIDs since discharge.
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She was treated for infected bullous ulcer 
with sepsis causing worsening AKI and cutaneous 
vasculitis. She was started on IV Piperacillin-
tazobactam, intravenous saline hydration, packed 
cell transfusions and oral Prednisolone of 40 mg 
daily. Ultrasound scan of the kidneys revealed 
normal kidneys size with no obstruction, 
urinalysis showed blood 3+ and protein 2+ with 
urine protein creatinine index (UPCI) of 0.28 g/
mmol creatinine. Urine phase contrast showed 
isomorphic red blood cells. She had a negative 
antinuclear antibody (ANA), normal C3 level of 
71.5 mg/dL and normal C4 level of 12.9 mg/dL. 
Panel immunoglobulin level was not raised with 
immunoglobulin (Ig) M of 20.3 mg/dL, IgG 767 
mg/dL, and IgA 209 mg/dL while cryoglobulins 
were also negative. Her infective screening for 
hepatitis B and C, human immunodeficiency 
virus (HIV), anti-streptolysin O titre (ASOT), 
venereal disease research laboratory (VDRL) 
test were all  negative with negative blood and 
urine culture and sensitivity (C+S). Meanwhile, 
a swab C+S of her wounds showed a mixed 
growth – a combination of gram-positive and 
gram-negative organisms.
A biopsy of the vasculitis lesions from 
her left shin (Figure 1) revealed moderate 
perivascular neutrophilic inflammatory infiltrates 
with nuclear debris over the superficial dermis, 
these were stained positive for C3, IgG and IgM 
on immunofluorescence study. The findings were 
consistent with leuko-cytoclastic vasculitis and 
suggestive of immune-mediated lesion. Her 
kidney function rapidly deteriorated and she 
required hemodialysis (HD). A renal biopsy was 
planned however it was postponed due to ongoing 
sepsis and thrombocytopenia with platelets of 
65x109/L. Her immunosuppressive medication 
was changed to IV Methylprednisolone 50 mg 
daily.
She progressed rapidly with multi-organ 
involvement; acute coronary syndrome due to 
carditis and hepatitis. She was dialysis dependent 
and still suffering from on-going sepsis. Due 
to severe organ involvement due to systemic 
vasculitis, she was given pulsed corticosteroid 
with IV Methylprednisolone 150 mg daily for 3 
days followed by 50 mg daily and was also given 
first dose of IV Cyclophosphamide to treat her 
active disease. Meanwhile, her antibiotic was 
escalated to IV Meropenem. She received only 
one session of plasmapheresis as she developed 
severe pancytopenia post procedure with Hb of 
7.3 g/dL, WCC of 1.0x109/L and platelets of 
36x109/L.
A computed tomography (CT) scan of 
thorax, abdomen and pelvis was performed 
to look for internal malignancy which was 
reported as negative. A qualitative test for 
cytoplasmic ANCA (c-ANCA) from a private 
laboratory was positive whilst perinuclear ANCA 
(p-ANCA) was negative. From the extensive 
investigations, she was treated aggressively 
for systemic vasculitis and multi-organ failure 
with superimposed sepsis due to cutaneous skin 
infections and the final diagnosis was attributed 
due to AAV.
Her clinical condition gradually improved 
with our aggressive measures and was given a 2nd 
dose of IV Cyclophosphamide. Unfortunately, 
she also suffered from severe depression from 
her illness needing selective serotonin re-uptake 
inhibitor (SSRI). She and her family were 
given extensive counselling on the disease and 
eventually they opted for conservative/palliative 
management. She finally succumbed to her 
illness.
DISCUSSION
Primary systemic vasculitis associated 
with anti-neutrophil cytoplasmic antibodies 
(ANCA) is one of the common causes of rapidly 
progressive glomerulonephritis. ANCAs are 
directed against several myeloid enzymes 
Figure 1. Skin biopsy (40 x magnifications) showing 
perivascular neutrophilic infiltration (arrow).
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namely c-ANCA and p-ANCA.3 Testing for 
ANCA is by enzyme-linked immunosorbent 
assay (ELISA) where c-ANCA reacts with 
proteinase 3 (ANCA-PR3) whilst p-ANCA 
reacts with myeloperoxidase (ANCA-MPO). 
ANCA-PR3-positivity is predominantly found in 
patients with granulomatous polyangiitis (GPA) 
and microscopic polyangiitis (MPA) meanwhile 
ANCA-MPO-positivity is found in patients 
with MPA and eosinophilic granulomatous 
polyangiitis (EGPA) as well as in patients with 
other vasculitides and auto-immune conditions.4
Our patient had biopsy-proven cutaneous 
vasculitis lesions with rapidly declining renal 
function that is attributed to rapidly progressive 
glomerulonephritis (RPGN) as well as sepsis 
which required hemodialysis support. Her skin 
biopsy was suggestive of immune-mediated 
vasculitis however, we were unable to proceed 
with a kidney biopsy as her platelets were low 
and her condition was unstable. Her plasma 
c-ANCA was positive and when we tied up 
together with her clinical conditions, these have 
led to the diagnosis of multi-systemic AAV. 
Despite the small percentage possibility co-
existent of ANCA and anti-GBM positivity, we 
did not proceed with further test even testing the 
ANCA with ELISA for MPO or PR3 specificity 
as it was very costly and would not change much 
of our current management.
 ANCA-associated glomerulonephritis is 
classically pauci-immune in nature from the 
renal histopathology immunofluorescence (IF) 
study and unfortunately, in this case, we were 
unable to perform the renal biopsy due to her 
ill condition. However, from the skin biopsy, it 
was stained positive for C3, IgG and IgM on IF. 
In literature, there were reported cases whereby 
immune complex deposits were found on skin 
and renal biopsies in AAV.5 A study by Haas 
and Eustace on 126 renal biopsies with ANCA-
associated or arteritis-associated necrotizing 
crescentic GN found that 15% had positive 
immunofluorescence microscopy findings for 
IgG, 49% for IgM, 57% for C3 and 8% for C1q.6 
As mentioned earlier, the exact pathogenesis 
and the significance of immune deposits in 
the affecting organs remain unclear. This case 
perhaps also illustrates the small percentage of 
cases that has positive ANCA in the plasma and 
her skin biopsy showed positivity for immune 
complexes.
This case was initially treated for acute contact 
dermatitis with superimposed bacterial infection 
causing cellulitis. Although she had mixed 
growth in swab culture, Staphylococcus aureus 
remains the most common organism leading 
to soft tissue infections in the community.7,8 
The hypothesis of an infectious agent such as 
Staphylococcus aureus triggering the immune 
system has been suggested before. This theory 
emerged based on the observation that up to 70% 
of patients with chronic nasal GPA are carriers of 
this microorganism.9,10 William et al.11 suggested 
role of infections as triggers for AAV and he also 
described anti-complement antibodies in patients 
with PR3-ANCA vasculitis. These antibodies 
were found to react to the peptide sequences from 
the complementary PR3-sequence, which has 
similarity with a number of infectious pathogens 
such as Staphylococcus aureus. Hence, infections 
as triggering factors for AAV is a valid argument 
and in our case, we hypothesis that her initial 
infected dermatitis as the inciting event to a full-
blown multi-systemic AAV.
Previous studies and case reports have 
shown the association between two autoimmune 
diseases occurring together either simultaneously 
or sequentially.12 Small vessels vasculitis has been 
reported to be associated with other autoimmune 
diseases.13,14 A population-based study reported 
that thyroid disease was prevalent at the time of 
diagnosis of AAV in as many as 40% of cases.14 
Tanaka et al.15 found 4 cases out of 10 with MPO-
ANCA positive nephropathy had hypothyroidism 
and two of them were subclinical. Concur to 
the report; Lai et al.16 also reported a case of 
AAV with Hashimoto’s thyroiditis in Malaysia. 
Similarly as we illustrated in this case, our patient 
was diagnosed to have hypothyroidism for 2 
years and was put on thyroxine replacement. 
Even though there were no investigations to 
determine the etiology of her hypothyroidism, it 
was possible the cause of her hypothyroidism is 
due to Hashimoto’s thyroiditis or due to iodine 
deficiency.17 We believe this case report supports 
the association between AAV and autoimmune 
thyroid diseases as suggested by previous studies.
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A AV  i s  a n  i m m u n e - m e d i a t e d 
disease; therefore its treatment involves 
immunosuppression to induce remission 
followed by maintenance therapy to prevent 
relapses. A multitude of treatment options can be 
incorporated with agents such as corticosteroid, 
azathioprine, methotrexate, mycophenolate 
mofetil, cyclophosphamide and anti CD-20 
monoclonal antibody such as Rituximab.18,19 
Therapies such as plasma exchange (PE) also 
can be used in combination or sequential with 
the immunosuppressive medications especially 
in cases of severe, refractory or relapsing AAV.20 
However, despite significant evidence-based 
advances in our treatment strategies, AAV 
remains a disease with substantial mortality and 
morbidity with worse prognosis in the elderly 
and for those with severe renal involvement.21,22
CONCLUSION
This case report suggests that cellulitis 
could be the trigger for the development of 
multi-systemic AAV. Her background history of 
hypothyroidism, potentially become a risk for 
such development and concur with very limited 
case reports before. Under these circumstances 
we need to have a high index of suspicion to 
detect AAV earlier and administer definitive 
treatment as soon as possible for a better 
prognosis to this devastating condition.
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